Genomind Inc.

King of Prussia, PA

UEI
TNYUTKB65UK9
CAGE
7CF71
Primary NAICS
621511 Medical Laboratories
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
2200 Renaissance Blvd #100, King of Prussia, PA 19406, USA
Website
genomind.com
Founded
2009
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Genomind Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Development of a patient-facing portal for the receipt, interpretation and tracking utility of pharmacogenetic (PGX)… Grant · R43HG013068 National Human Genome Research Institute $799,186

Contract vehicles

Quick answers

What is Genomind Inc.'s UEI?

Genomind Inc.'s Unique Entity ID (UEI) in SAM.gov is TNYUTKB65UK9.

What is Genomind Inc.'s CAGE code?

Genomind Inc.'s CAGE code is 7CF71.

What is Genomind Inc.'s primary NAICS code?

Genomind Inc.'s primary NAICS code is 621511 (Medical Laboratories).

Where is Genomind Inc. located?

Genomind Inc.'s physical address in SAM.gov is 2200 Renaissance Blvd #100, King of Prussia, PA 19406, USA.

Is Genomind Inc. registered in SAM.gov?

Yes. Genomind Inc.'s SAM.gov registration is active through February 10, 2027.

Which contract vehicles does Genomind Inc. hold?

Genomind Inc. holds a place on 1 federal contract vehicle: FSS-621-II.

What is Genomind Inc.'s most recent federal award?

Genomind Inc.'s most recent federal grant award is Development of a patient-facing portal for the receipt, interpretation and tracking utility of pharmacogenetic (PGX)… (R43HG013068), from National Human Genome Research Institute, on September 21, 2023.

On GovTribe

See Genomind Inc.'s full federal record

  • IDV awards
  • Contract vehicles
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors